Human iNKT cell-derived iPSCs have differentiated into Vα24 iNKT-like cells in vitro
Re-differentiated iNKT-like (Re-iNKT) cells have functionally recovered properties
Re-iNKT cells function as an adjuvant to activate antigen-specific CTLs and NK cells
Re-iNKT cells exert cytotoxic activity via NKG2D- and DNAM-1-dependent mechanism